Skip to content

C-Reactive Protein (CRP) Gene Variants and Coronary Artery Disease in a Chinese Han Population

CRP Gene Variants and Coronary Artery Disease in a Chinese Han Population

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00780221
Acronym
CRP-Han
Enrollment
1000
Registered
2008-10-27
Start date
2008-10-31
Completion date
2010-12-31
Last updated
2008-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

CRP, coronary artery disease, polymorphisms

Brief summary

The recognition of the association between circulating C-reactive protein (CRP) levels and risk of coronary heart disease (CHD) has led to an increased emphasis on CRP genetic effects on CRP level and CHD. However, the causality of CRP variants remains uncertain.The objective of this study is to evaluate the association of CRP gene variants and CRP levels in CHD in Chinese Han population. We conduct case-control study in CRP-Han study participants. The common single-nucleotide polymorphisms (SNPs) in the CRP gene, haplotypes, and plasma CRP levels are detected. A Mendelian randomization analysis will be used to help test the likelihood of causal association of gene-CRP levels, CRP levels-CHD and gene-CHD. The investigators hypothesize that CRP gene variants influence the protein level and may participate in CHD progress.

Detailed description

CHD patients and non-CHD population are recruited. CRP level and CHD severity by coronary angiograph will be examined. Mendelian randomization analysis are taken to analyze statically.

Interventions

None listed

Sponsors

Fudan University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* clinical diagnosis of coronary artery disease

Exclusion criteria

* with major organ disfunction or acute inflammatory disease

Countries

China

Contacts

Primary ContactChaoneng Wu, PhD
wuchaoneng@hotmail.com+86-21-64041990

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026